Miss Elaine McCartney
- Bio statistician (Clinical Research Gartnavel)
email:
Elaine.McCartney@glasgow.ac.uk
Cancer Research UK, Clinical Trials Unit Level 0, Beatson Cancer Centre, 1053 Great Western Road G12 0YN
https://orcid.org/0000-0002-0260-4161Publications
2023
Rushworth, L. K. et al. (2023) Phase II proof of concept study of atorvastatin in castration resistant prostate cancer. BJU International, 131(2), pp. 236-243. (doi: 10.1111/bju.15851) (PMID:35844167)
2021
Moss, J. G. et al. (2021) Central venous access devices for the delivery of systemic anticancer therapy (CAVA): a randomised controlled trial. Lancet, 398(10298), pp. 403-415. (doi: 10.1016/S0140-6736(21)00766-2) (PMID:34297997)
Wu, O. et al. (2021) Venous access devices for the delivery of long-term chemotherapy: the CAVA three-arm RCT. Health Technology Assessment, 25(47), (doi: 10.3310/hta25470)
2019
Zhou, C. et al. (2019) Dynamics of circulating vascular endothelial growth factor-A predict benefit from antiangiogenic cediranib in metastatic or recurrent cervical cancer patients. British Journal of Clinical Pharmacology, 85(8), pp. 1781-1789. (doi: 10.1111/bcp.13965) (PMID:30980733) (PMCID:PMC6624436)
Hatton, M. Q.F. et al. (2019) Accelerated, dose escalated, sequential chemoradiotherapy in non-small-cell lung cancer (ADSCaN): a protocol for a randomised phase II study. BMJ Open, 9(1), e019903. (doi: 10.1136/bmjopen-2017-019903) (PMID:30700475) (PMCID:PMC6352760)
2017
Lawless, C.A. et al. (2017) ADSCaN: a randomised phase II study of accelerated, dose escalated, sequential chemo-radiotherapy in non-small cell lung cancer (NSCLC). UNSPECIFIED S80-S81. (doi: 10.1016/S0169-5002(17)30221-0)
2016
Wu, O. , Boyd, K. , Paul, J. , McCartney, E. , Ritchie, M., Mellon, D., Kelly, L., Dixon-Hughes, J. and Moss, J. (2016) Hickman catheter and implantable port devices for the delivery of chemotherapy: a phase II randomised controlled trial and economic evaluation. British Journal of Cancer, 114(9), pp. 979-985. (doi: 10.1038/bjc.2016.76) (PMID:27092784)
Marshall-Mckenna, R. , Morrison, A., Stirling, L., Hutchison, C., Rice, A.M., Hewitt, C., Paul, L., Rodger, M., MacPherson, I. and McCartney, E. (2016) A randomised trial of the cool pad pillow topper versus standard care for sleep disturbance and hot flushes in women on endocrine therapy for breast cancer. Supportive Care in Cancer, 24(4), pp. 1821-1829. (doi: 10.1007/s00520-015-2967-3) (PMID:26446702)
2015
Symonds, R. P. et al. (2015) Cediranib combined with carboplatin and paclitaxel in patients with metastatic or recurrent cervical cancer (CIRCCa): a randomised, double-blind, placebo-controlled phase 2 trial. Lancet Oncology, 16(15), pp. 1515-1524. (doi: 10.1016/S1470-2045(15)00220-X) (PMID:26474517) (PMCID:PMC4705431)
2013
Ahmad, I., Kalna, G., Ismail, M., Birrell, F., Asterling, S., McCartney, E. , Greene, D., Davies, J. and Leung, H.Y. (2013) Prostate gland lengths and iceball dimensions predict micturition functional outcome following salvage prostate cryotherapy in men with radiation recurrent prostate cancer. PLoS ONE, 8(8), e69243. (doi: 10.1371/journal.pone.0069243) (PMID:23950886) (PMCID:PMC3739755)
White, J. D. et al. (2013) RESTART: Rehabilitation Evaluation in Survivors of Testicular Cancer after Radical Treatment-Pilot study effect on HADS-anxiety subscore. Journal of Clinical Oncology, 31,
2012
Carruthers, R. , Tho, L.M., Brown, J., Kakumanu, S., McCartney, E. and McDonald, A.C. (2012) Systemic inflammatory response is a predictor of outcome in patients undergoing preoperative chemoradiation for locally advanced rectal cancer. Colorectal Disease, 14(10), e701-e707. (doi: 10.1111/j.1463-1318.2012.03147.x)
Articles
Rushworth, L. K. et al. (2023) Phase II proof of concept study of atorvastatin in castration resistant prostate cancer. BJU International, 131(2), pp. 236-243. (doi: 10.1111/bju.15851) (PMID:35844167)
Moss, J. G. et al. (2021) Central venous access devices for the delivery of systemic anticancer therapy (CAVA): a randomised controlled trial. Lancet, 398(10298), pp. 403-415. (doi: 10.1016/S0140-6736(21)00766-2) (PMID:34297997)
Wu, O. et al. (2021) Venous access devices for the delivery of long-term chemotherapy: the CAVA three-arm RCT. Health Technology Assessment, 25(47), (doi: 10.3310/hta25470)
Zhou, C. et al. (2019) Dynamics of circulating vascular endothelial growth factor-A predict benefit from antiangiogenic cediranib in metastatic or recurrent cervical cancer patients. British Journal of Clinical Pharmacology, 85(8), pp. 1781-1789. (doi: 10.1111/bcp.13965) (PMID:30980733) (PMCID:PMC6624436)
Hatton, M. Q.F. et al. (2019) Accelerated, dose escalated, sequential chemoradiotherapy in non-small-cell lung cancer (ADSCaN): a protocol for a randomised phase II study. BMJ Open, 9(1), e019903. (doi: 10.1136/bmjopen-2017-019903) (PMID:30700475) (PMCID:PMC6352760)
Wu, O. , Boyd, K. , Paul, J. , McCartney, E. , Ritchie, M., Mellon, D., Kelly, L., Dixon-Hughes, J. and Moss, J. (2016) Hickman catheter and implantable port devices for the delivery of chemotherapy: a phase II randomised controlled trial and economic evaluation. British Journal of Cancer, 114(9), pp. 979-985. (doi: 10.1038/bjc.2016.76) (PMID:27092784)
Marshall-Mckenna, R. , Morrison, A., Stirling, L., Hutchison, C., Rice, A.M., Hewitt, C., Paul, L., Rodger, M., MacPherson, I. and McCartney, E. (2016) A randomised trial of the cool pad pillow topper versus standard care for sleep disturbance and hot flushes in women on endocrine therapy for breast cancer. Supportive Care in Cancer, 24(4), pp. 1821-1829. (doi: 10.1007/s00520-015-2967-3) (PMID:26446702)
Symonds, R. P. et al. (2015) Cediranib combined with carboplatin and paclitaxel in patients with metastatic or recurrent cervical cancer (CIRCCa): a randomised, double-blind, placebo-controlled phase 2 trial. Lancet Oncology, 16(15), pp. 1515-1524. (doi: 10.1016/S1470-2045(15)00220-X) (PMID:26474517) (PMCID:PMC4705431)
Ahmad, I., Kalna, G., Ismail, M., Birrell, F., Asterling, S., McCartney, E. , Greene, D., Davies, J. and Leung, H.Y. (2013) Prostate gland lengths and iceball dimensions predict micturition functional outcome following salvage prostate cryotherapy in men with radiation recurrent prostate cancer. PLoS ONE, 8(8), e69243. (doi: 10.1371/journal.pone.0069243) (PMID:23950886) (PMCID:PMC3739755)
White, J. D. et al. (2013) RESTART: Rehabilitation Evaluation in Survivors of Testicular Cancer after Radical Treatment-Pilot study effect on HADS-anxiety subscore. Journal of Clinical Oncology, 31,
Carruthers, R. , Tho, L.M., Brown, J., Kakumanu, S., McCartney, E. and McDonald, A.C. (2012) Systemic inflammatory response is a predictor of outcome in patients undergoing preoperative chemoradiation for locally advanced rectal cancer. Colorectal Disease, 14(10), e701-e707. (doi: 10.1111/j.1463-1318.2012.03147.x)
Conference or Workshop Item
Lawless, C.A. et al. (2017) ADSCaN: a randomised phase II study of accelerated, dose escalated, sequential chemo-radiotherapy in non-small cell lung cancer (NSCLC). UNSPECIFIED S80-S81. (doi: 10.1016/S0169-5002(17)30221-0)